-
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines
Pothast, C. R., Hofsink, Q., Haggenburg, S., Dijkland, R. C., van de Meent, M., van Dijk, K., Bhoekhan, M. S., Haverkate, N. J. E., van Meerloo, J., Falkenburg, J. H. F., de Groen, R. A. L., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Lissenberg-Witte, B. I., Kater, A. P., Smits, G. P., Wouters, D. & van Leeuwen, E. M. M. & 13 others, , 1 Nov 2025, In: Haematologica. 110, 11, p. 2799-2805Research output: Contribution to journal › Article › Academic › peer-review
-
Vaccination in patients with a hematologic condition: Challenging the dogmas in vaccination of the immunocompromised
Haggenburg, S., 2025, 342 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
-
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
Campanella, A., Capasso, A., Heltai, S., Taccetti, C., Albi, E., Herishanu, Y., Haggenburg, S., Chatzikonstantinou, T., Doubek, M., Kättström, M., Giannopoulos, K., Simkovic, M., Moreno, C., Massaia, M., Bumbea, H., Alshemmari, S., Ranghetti, P., Perotta, E., Martini, F. & Sant'Antonio, E. & 24 others, , Apr 2024, In: American Journal of Hematology. 99, 4, p. 745-750 6 p.Research output: Contribution to journal › Letter › Academic › peer-review
- All publications
